Standard Operating Procedure for CMC Documentation Approval Matrix
| Department | Regulatory Affairs |
| SOP No. | RA/2026/722 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 14/04/2026 |
| Effective Date | 14/04/2026 |
| Review Date | 14/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines the process for preparing, reviewing, approving, and maintaining the Chemistry, Manufacturing, and Controls (CMC) documentation approval matrix. The purpose is to ensure clear, consistent, and controlled documentation workflows that comply with regulatory requirements, support timely submissions, and maintain integrity and traceability of CMC documents throughout their lifecycle.
Scope
This SOP applies to all CMC documentation generated, reviewed, and approved within the Regulatory Affairs department and cross-functional teams involved in dossier preparation, submission management, and compliance activities. It encompasses documents related to product development, manufacturing process descriptions, validation reports, stability data, and quality controls. This SOP excludes non-CMC regulatory documents such as pharmacovigilance reports and marketing materials.
Responsibilities
The following roles are responsible for executing and supporting the CMC documentation approval matrix process:
- Regulatory Affairs Specialists – prepare and coordinate CMC documentation.
- Quality Assurance – review and approve documents for compliance and accuracy.
- Functional Area Heads – authorize technical and operational content.
- Document Control Personnel – maintain approved documentation and archive records.
- Regulatory Managers – oversee the documentation approval workflow and ensure timelines.
Accountability
The Head of Regulatory Affairs holds accountability for the implementation, compliance, periodic review, and effectiveness of this SOP. They are responsible for escalation of issues, approving changes, and ensuring audit readiness of the CMC documentation approval matrix and related processes.
Procedure
The following procedure outlines the stepwise approach to establish, implement, and maintain the CMC Documentation Approval Matrix to ensure regulatory compliance and operational integrity.
1. Preparation and Definition: Define the scope of documents requiring approval per product and regulatory submission type. Identify and document all functional roles and department inputs necessary for each document type within the approval matrix. Update organizational roles as applicable.
2. Creation of the Approval Matrix: Develop a matrix document listing each CMC document or document category against the designated approvers, reviewers, and preparers. Specify approval levels required (e.g., initial review, technical approval, final approval) and timelines for each stage.
3. Review and Validation: Circulate the draft approval matrix among key stakeholders including Regulatory Affairs, Quality Assurance, and Functional Heads for input and consensus. Address comments and finalize the approval matrix ensuring alignment with organizational quality management systems and regulatory expectations.
4. Implementation and Communication: Distribute and communicate the approved matrix to all relevant personnel involved in documentation preparation and approval processes. Conduct training sessions as necessary to ensure understanding and compliance.
5. Use During Documentation Lifecycle: Apply the matrix during each stage of CMC document development – preparation, review, and approval. The matrix serves as a guide to ensure documents undergo appropriate verification and authorization levels before release.
6. Monitoring and Compliance: Periodically audit the use of the approval matrix to confirm adherence. Investigate any deviations or delays, implement corrective actions, and document findings per quality management procedures.
7. Review and Update: Review the approval matrix at least annually or following any significant organizational, regulatory, or process changes. Update roles, approval requirements, or document categories as needed. Ensure repeat review and approval cycle is documented.
8. Documentation and Record Retention: Maintain all versions of the approval matrix, review records, training documentation, and related correspondence in accordance with internal record retention policies and regulatory requirements. Ensure traceability and ease of retrieval for audits or inspections.
This structured procedure ensures controlled management of CMC documentation approvals, facilitates regulatory submission readiness, minimizes risks of non-compliance, and maintains quality and accountability within regulatory affairs operations.
Abbreviations
CMC – Chemistry, Manufacturing, and Controls
QA – Quality Assurance
SOP – Standard Operating Procedure
RA – Regulatory Affairs
GMP – Good Manufacturing Practice
Documents
The following documents are essential for the effective implementation and maintenance of the CMC Documentation Approval Matrix:
- CMC Documentation Approval Matrix Template (Annexure-1)
- Approval Matrix Review and Change Log (Annexure-2)
- Training Attendance Record on Approval Matrix Procedure (Annexure-3)
References
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q9 – Quality Risk Management
European Medicines Agency (EMA) – GMP Guidelines
US FDA – Guidance for Industry: Electronic Source Data in Clinical Investigations
ICH Q10 – Pharmaceutical Quality System
Internal Quality Management System documentation
Pharmaceutical regulatory submission requirements and dossier standards
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: CMC Documentation Approval Matrix Template
Purpose: This template provides a structured format to list CMC documents alongside the respective roles responsible for preparation, review, and approval, including approval levels and target timelines.
| Document/Category | Prepared By | Reviewed By | Approved By | Approval Level | Target Timeframe (Days) |
|---|---|---|---|---|---|
| Product Development Report | Regulatory Affairs Specialist | Quality Assurance | Functional Area Head | Final Approval | 15 |
| Manufacturing Process Description | Regulatory Affairs Specialist | Manufacturing Manager | Quality Assurance Manager | Technical and Final Approval | 10 |
| Validation Summary Report | Validation Team | Quality Assurance | Head of Regulatory Affairs | Final Approval | 12 |
| Stability Data Report | Analytical Lab | Quality Control Manager | Regulatory Manager | Technical and Final Approval | 20 |
| Change Control Documentation | Change Control Coordinator | Quality Assurance | Regulatory Affairs Manager | Final Approval | 7 |
Annexure-2: Approval Matrix Review and Change Log
Purpose: To document all reviews, updates, and changes made to the CMC Documentation Approval Matrix including date, description of change, reason, and authorized approver.
| Review Date | Reviewed By | Change Description | Reason for Change | Approved By |
|---|---|---|---|---|
| 14/04/2026 | Quality Assurance Representative | Initial creation and approval of matrix | Establish controlled process | Regulatory Manager |
| 14/10/2027 | Regulatory Affairs Specialist | Updated approval roles and timelines for validation reports | Process efficiency improvement | Head of Regulatory Affairs |
Annexure-3: Training Attendance Record on Approval Matrix Procedure
Purpose: To record details of personnel trained on the CMC Documentation Approval Matrix procedure ensuring awareness and compliance.
| Training Date | Employee ID | Department | Training Method | Trainer | Signature |
|---|---|---|---|---|---|
| 20/04/2026 | EMP01234 | Regulatory Affairs | Instructor-led Session | Quality Assurance | ___________________ |
| 22/04/2026 | EMP01567 | Quality Assurance | e-Learning Module | Regulatory Trainer | ___________________ |
| 25/04/2026 | EMP01011 | Manufacturing | Instructor-led Session | Regulatory Trainer | ___________________ |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 14/04/2026 | 1.0 | Initial issue | New SOP creation |